NCT03840382

Brief Summary

This study will develop and test a program to deliver PrEP care in underserved communities in Mississippi (MS) through telemedicine, distance-based, clinical care delivered in local community based organizations (CBOs). The intervention will be developed in collaboration with medical specialists at the University of Mississippi Medical Center (UMMC) and local CBO stakeholders (providers, administrators and patients). Approximately 75 individuals will be recruited from CBOs in MS. Participants will be able to receive PrEP counseling in the CBO and PrEP care via telemedicine from a PrEP specialist at UMMC. Participants will complete three assessments in the six months after enrolling. Our study will provide a wealth of information about PrEP-related outcomes and HIV testing among MS residents living in underserved communities. If successful, this program will be able to be disseminated to other CBOs in the South.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2019

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 15, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

December 19, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2022

Completed
2 years until next milestone

Results Posted

Study results publicly available

April 29, 2024

Completed
Last Updated

April 29, 2024

Status Verified

November 1, 2023

Enrollment Period

2.4 years

First QC Date

January 28, 2019

Results QC Date

October 14, 2022

Last Update Submit

November 14, 2023

Conditions

Outcome Measures

Primary Outcomes (7)

  • Number of Participants Who Attended One or More PrEP Telemedicine Appointments at 3 Months Post-intervention (Electronic Medical Record Extraction)

    Number of participants who attended one or more PrEP telemedicine appointments with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record at 3 months post-intervention.

    Assessed at 3 months

  • Number of Participants Who Attended One or More PrEP Telemedicine Appointments at 6 Months Post-intervention (Electronic Medical Record Extraction)

    Number of participants who attended one or more PrEP telemedicine appointments with a UMMC PrEP specialist, in the past 3 months, extracted from patient's electronic medical record at 6 months post-intervention.

    Assessed at 6 months

  • Number of Participants Who Received a PrEP Medication Prescription at 3 Months (Electronic Medical Record Extraction)

    Number of participants who received a PrEP medication prescription in past 3 months, extracted from patient's electronic medical record at 3-month follow-up.

    Assessed at 3 months

  • Number of Participants Who Received a PrEP Medication Prescription at 6 Months (Electronic Medical Record Extraction)

    Number of participants who received a PrEP medication prescription in past 3 months, extracted from patient's electronic medical record at 6-month follow-up.

    Assessed at 6 months

  • Adherence to PrEP (Self-report)

    Self-reported number of days a PrEP dose was missed in the past 30 days. Ranging from 0 to 30.

    Assessed at 3 months and 6 months

  • Number of Participants With 0-2 PrEP Refills at 3 Months (Electronic Medical Record )

    Number of participants with 0-2 PrEP medication refills in past 3 months (extracted from electronic medical record at 3-month follow-up).

    Assessed at 3 months

  • Number of Participants With 0-2 PrEP Refills at 6 Months (Electronic Medical Record)

    Number of Participants With 0-2 PrEP Refills in past 3 months (extracted from electronic medical record at 6-month follow-up).

    Assessed at 6 months

Secondary Outcomes (3)

  • PrEP Knowledge

    Assessed at 3 months and 6 months

  • Motivational Readiness for PrEP and PrEP-related Care

    Assessed at 3 months and 6 months

  • Patient Acceptability Score Regarding the Use of Telemedicine for PrEP Care (CSQ-8)

    Assessed at 3 months and 6 months

Study Arms (1)

Tele-PrEP Intervention

EXPERIMENTAL

The telemedicine intervention will allow participants to discuss HIV prevention and PrEP with PrEP specialists at an academic medical center via videoconference from their local community based organization (CBO). During the intervention, participants will gain information related to HIV and PrEP, view a video to improve motivation for engagement in PrEP related care, and receive resources to address barriers to care.

Behavioral: Tele-PrEP Intervention

Interventions

Telemedicine conferences with PrEP-specialists

Tele-PrEP Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • Presented at a collaborating CBO for HIV testing during trial months
  • PrEP eligible based on HIV Risk Checklist
  • Able to read and speak English
  • Able to give meaningful consent as determined by research staff
  • No known HIV infection

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Mississippi Medical Center

Jackson, Mississippi, 39216, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Dr. Larry Brown
Organization
Rhode Island Hospital

Study Officials

  • Larry K Brown, MD

    Rhode Island Hospital

    PRINCIPAL INVESTIGATOR
  • James B Brock, MD

    University of Mississippi Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Division of Child and Adolescent Psychiatry

Study Record Dates

First Submitted

January 28, 2019

First Posted

February 15, 2019

Study Start

December 19, 2019

Primary Completion

May 4, 2022

Study Completion

May 4, 2022

Last Updated

April 29, 2024

Results First Posted

April 29, 2024

Record last verified: 2023-11

Locations